Fight Against Parkinson's: The First Argentine Startup Launched to Innovate with Stem Cells
The first Argentine startup focused on stem cell innovations for treating Parkinson's and heart conditions has been launched, inspired by recent advancements in Japan.
[Pharmaceutical Bio News] Chabaitech and Novartis Korea to Establish 'Open Innovation Center' in Second Half of This Year
Chabaitech and Novartis Korea have signed a strategic MoU to establish an Open Innovation Center aimed at supporting biotech startups.
War Conflict and Bioeconomy: A New Opportunity for Argentina
The article discusses the potential of bioeconomy in Argentina amidst the ongoing Middle Eastern conflict, emphasizing its benefits for investment, employment, and sustainable production.
NIH-awarded life scientist Shu Xiaokun abruptly shifts research from US to China
Shu Xiaokun, a renowned life scientist, has announced his sudden move from a prestigious role in the US to lead a new institute in Shanghai, China.
Opinion: why Argentina needs a new seed law
The article discusses the need for Argentina to update its seed legislation from 1973 to encourage investment and innovation in biotechnology and agriculture.
Regeneron Chooses Milan: Italy as a Strategic Hub for Biotechnological Innovation
Regeneron has opened a new office in Milan, solidifying Italy's status as a key destination for foreign biotech investments.
Broad businesses: the millionaire assets of the group behind the bankruptcy of Bioceres SA
Moolec Science SA, which controlled the recently bankrupt Bioceres SA, holds over $160 million in investments related to seeds, ingredients, and biotechnology.
She was a surrogate for the family โ now the question divides Norway
A new survey indicates that nearly half of Norwegians are in favor of legalizing surrogacy, though political and professional opinions remain divided.
Joining Forces for Sustainable Development in Biotechnology and Health in Mexico
The article discusses the necessity of collaboration among public, private, and academic sectors in Mexico to advance sustainable projects in biotechnology and health.
Reviving extinct species? The famous U.S. company that promises to bring back the woolly mammoth made a new announcement
Colossal Biosciences claims it is on the verge of bringing extinct animals back to life through genetic editing and ancient DNA.
Breakthrough in the fight against cancer and dengue getting closer? Poles are looking for drugs and going to the stock exchange
A Polish biotech start-up, Vaxican, is nearing 4.5 million PLN in funding to advance innovative diagnostic and therapeutic methods against arboviruses, driven by rising health challenges and climate change.
From Ocean to Table.. Scientists Transform Plastic Waste into Vinegar
Canadian scientists have developed a new technology to convert plastic waste into acetic acid, the main component of vinegar, addressing the pressing environmental crisis of plastic pollution.
Is Jurassic Park Possible? A Story of How Elon Musk Brought Dinosaurs Back to Life with Six Words
Elon Musk claims it's possible to recreate Jurassic Park, sparking global conversation about the feasibility of resurrecting dinosaurs.
Oman Advances Towards Large-Scale Seaweed Farming
Researchers in Oman are launching a pilot seaweed farming project to assess the commercial viability of local species in Oman's waters.
Will robot cockroaches join the war after drones? They will be involved in espionage and warfare.
A German startup is developing technology to turn cockroaches into robotic spies for military missions using small electronic backpacks.
Without labels, control or precaution: deregulating genetically modified organisms in Europe would entail serious risks
The European Parliament is facing a critical decision regarding the deregulation of genetically modified organisms (GMOs), which could soon allow such foods to be sold without proper labeling or risk assessment.
Biotechnology: The departure of the founders is a disaster for Biontech
The stock price of Biontech plummeted by about 20% following the announcement of founders Uฤur ลahin and รzlem Tรผreci stepping back from the company by the year's end.
The National People's Congress of China Approved a New Five-Year Plan
China's new five-year plan emphasizes sectors like robotics and biotechnology to strengthen its technological capacities.
Personalized Medicine Thanks to Genetics
ConGen, a biotechnology company founded by biologists in Spain, aims to enhance personalized medicine through genetics and has achieved significant recognition and growth since its inception.
Seeds: The Liaison Table presented a proposal to the Government to reform current law and regulate self-use
In Argentina, the Liaison Table presented a proposal to the government to reform existing seed legislation amidst debates on adopting the UPOV-91 agreement, while still adhering to the UPOV-78 framework.
Enzyme discovered by scientists can transform agricultural waste into energy
Scientists have identified a new enzyme that can convert agricultural waste, such as sugarcane bagasse, corn husks, and wood shavings, into biofuels and other sustainable products.
Pharmaceutical Industry: BioNTech Founders Leave Company
BioNTech founders Uฤur ลahin and รzlem Tรผreci will leave the company by the end of 2026 to start a new biotechnology firm focused on developing the next generation of mRNA-based drugs, while remaining shareholders in BioNTech.
Pharmaceutical industry: BioNTech founders leave the company
BioNTech founders Uฤur ลahin and รzlem Tรผreci will leave the company by the end of 2026 to establish a new biotechnology firm focused on mRNA-based medications while retaining a minority stake in BioNTech.
Pharma Pioneers: Founders Ugur Sahin and รzlem Tรผreci Leave Biontech
Biontech founders Ugur Sahin and รzlem Tรผreci are set to leave the company to start a new biopharmaceutical venture focusing on mRNA-based medications.
Good news in Illinois: Pritzker announces historic investment of $1.5 billion that will create hundreds of 'well-paid' jobs
Illinois Governor J.B. Pritzker announced a $1.5 billion investment from Australian biotechnology company CSL to establish a new manufacturing facility, creating 300 well-paid jobs.
These 200,000 brain cells play a shooting game all on their own: โ Well done! But now you must stop immediately.
Researchers have developed a chip containing 200,000 living human nerve cells that are capable of playing the classic video game 'Doom' independently.
Between the Vow of Mary and Cambridge Research: Fasting as the Oldest Biotechnological Therapy for Healing
The article discusses the historical and scientific significance of fasting, highlighting its potential health benefits and various forms beyond just religious practices.
Black Soldier Fly Larvae: A Natural Solution to Reduce Waste Viruses
A new study reveals that black soldier fly larvae may effectively treat organic waste and decrease certain viral pathogens it contains.
Only 200 thousand human brain cells manage to cope with playing a bloody cult game
Australian biotech startup Cortical Labs has successfully programmed 200,000 human brain cells to play the video game Doom, showcasing the potential for biological processors to outperform conventional silicon chips.
The Biotech Scandal Affects Serious Companies, They Had to Raise Money Quickly Elsewhere
The cancellation of a questionable grant call has negatively impacted several top biotechnology startups in Slovakia, forcing them to seek alternative funding.
EU strips AI, chips and quantum from industrial plan aimed at countering China
The EU's Industrial Accelerator Act will exclude AI, chips, quantum technologies, biotechnology, and robotics to promote local industries and reduce dependency on China.
Vytenis Povilas Andriukaitis. Lithuania's Chance to Shape Europe's Direction in Biotechnology Races
Lithuania's upcoming presidency of the EU Council in 2027 presents a unique opportunity to influence European biotech policy and innovation.
Polylaminin is not yet a drug: specialists warn against 'hype' on social media
Experts caution that the biotechnological compound polylaminin, popularized for its potential in treating spinal cord injuries, is still unproven and should not be considered a cure.
A European country presents biotechnological insects for military use at NATO
A German startup announced the deployment of biotechnological insect systems for military use at NATO, with confirmed field trials and plans for future missions focused on detection and reconnaissance.
Karol Nawrocki's Advisor Under Scrutiny. He Was Allegedly to Enrich Himself by 400 Thousand.
Paweล Gruza, an advisor to Karol Nawrocki, is under investigation for allegedly profiting from insider trading involving confidential information related to a biotechnology company.
The first clinical trial to 'reprogram' human aging is launched
The first human clinical trial aimed at reversing aging processes has begun, announced by Dr. David Sinclair at the World Government Summit.
Biotech key to Russiaโs industrial sovereignty โ Putin
President Putin emphasizes the strategic importance of biotechnology supported by AI for Russia's industrial sovereignty during the Future Technologies Forum in Moscow.
New megatrends in education. Universities will train experts in critical technologies
Polish universities are set to receive significant support to adapt their educational offerings towards critical technologies that will strengthen economic resilience.
Novo on the way with a new weight loss drug
Novo Nordisk has released data from a study on a weight loss drug developed in collaboration with Chinese company United Biotechnology, showing significant weight loss among participants.
Extinct ancient wolves are back: the first individuals have reached adulthood and hunt in packs
Colossal Biosciences celebrates a milestone in its project of resurrecting extinct species as genetically recreated ancient wolves have reached adulthood and begun hunting in packs, indicating a hopeful future for the species.
Kerecis' 40 Billion Payment Turns State Deficit into Surplus
Kerecis is set to make a substantial payment to the Icelandic state, improving the financial outlook by converting a deficit into a surplus.
Brazilian biotechnology uses drones and reduces dredging in sanitation
Brazilian company Legun Biotecnologia is innovating in public sanitation by using drones to apply biological treatment in stabilization ponds.
Agricultural Experiments: New Crops in the Field Thanks to Gene Editing?
The article discusses the potential for new crops developed through modern genetic modification techniques to be cultivated in the European Union, and the mixed reactions these developments spark.
Chinese scientists engineer gene-edited tomato with popcorn aroma
Chinese scientists have developed a gene-edited tomato that emits a buttered popcorn aroma by silencing specific genes using the CRISPR/Cas9 technique.
DNA vaccine will not change, says Czech scientist
A Czech scientist asserts that the DNA vaccine will not bring about significant changes.
Chinaโs biotech boom sends price of lab monkeys for drug tests climbing
The prices of laboratory monkeys in China for drug testing have surged dramatically, exceeding the average annual salary in the country.
One by one: what are the new university courses in Argentina
Argentina's universities are introducing new degree programs focused on technology, health, and digital finance for the 2026 academic cycle.
Kos Biotechnology financed the biopharmaceutical Epikast
Kos Biotechnology Partners has completed a funding round for the New York-based biopharmaceutical company Epikast, which has key operations in Athens.
These are the new university degrees that can be studied from this year in Argentina
Argentinian universities are introducing new degree programs in response to the evolving job market, including areas such as artificial intelligence and biotechnology.
Mergers and acquisitions are changing the landscape in the pharmaceutical industry
International and Greek pharmaceutical mergers and acquisitions are on the rise, focusing on innovative drugs and expiring patents.